Open
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

39 trades

Disclosure transactions for SEALSQ Corp Ordinary Shares
Reporting person Filed Transaction Transaction value Source Actions
Enguent Jean-pierre Vice President, R&dss Nov 3, 2026 Same-day filing Sale Nov 3, 2026 $48.33K Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Nov 3, 2026 1-day lag Exercise Nov 2, 2026 $200 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Nov 3, 2026 1-day lag Award Nov 2, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Nov 3, 2026 1-day lag Exercise Nov 2, 2026 $150 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Nov 3, 2026 1-day lag Exercise Nov 2, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Nov 3, 2026 1-day lag Exercise Nov 2, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Oct 7, 2026 1-day lag Sale Oct 6, 2026 $85.94K Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Oct 7, 2026 2-day lag Exercise Oct 5, 2026 $350 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Oct 7, 2026 2-day lag Exercise Oct 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Oct 7, 2026 2-day lag Award Oct 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Ward Peter Director Oct 6, 2026 1-day lag Award Oct 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Ward Peter Director Oct 6, 2026 1-day lag Award Oct 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Fergusson David Alexander Director Oct 6, 2026 11-day lag Award Sep 25, 2026 $0 Filed shares x price SEC Form 4 View filing
Fergusson David Alexander Director Oct 6, 2026 11-day lag Award Sep 25, 2026 $0 Filed shares x price SEC Form 4 View filing
Pellaton Eric Adrien Director Oct 6, 2026 11-day lag Award Sep 25, 2026 $0 Filed shares x price SEC Form 4 View filing
Pellaton Eric Adrien Director Oct 6, 2026 11-day lag Award Sep 25, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Sep 3, 2026 Same-day filing Sale Sep 3, 2026 $36.03K Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Sep 3, 2026 2-day lag Exercise Sep 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Sep 3, 2026 2-day lag Exercise Sep 1, 2026 $150 Filed shares x price SEC Form 4 View filing
Enguent Jean Pierre Vice President, R&Dss Aug 5, 2026 Same-day filing Sale Aug 5, 2026 $36.86K Filed shares x price SEC Form 4 View filing
Enguent Jean Pierre Vice President, R&Dss Aug 5, 2026 2-day lag Exercise Aug 3, 2026 $150 Filed shares x price SEC Form 4 View filing
Enguent Jean Pierre Vice President, R&Dss Aug 5, 2026 2-day lag Exercise Aug 3, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Jul 8, 2026 Same-day filing Sale Jul 8, 2026 $42.27K Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Jul 8, 2026 2-day lag Exercise Jul 6, 2026 $0 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss Jul 8, 2026 2-day lag Exercise Jul 6, 2026 $150 Filed shares x price SEC Form 4 View filing
Ward Peter Director Jun 18, 2026 2-day lag Disposition Jun 16, 2026 $296.35K Filed shares x price SEC Form 4 View filing
Ward Peter Director Jun 18, 2026 2-day lag Exercise Jun 16, 2026 $3.67K Filed shares x price SEC Form 4 View filing
Ward Peter Director Jun 18, 2026 2-day lag Exercise Jun 16, 2026 $0 Filed shares x price SEC Form 4 View filing
Ward Peter Director Jun 18, 2026 2-day lag Exercise Jun 16, 2026 $0 Filed shares x price SEC Form 4 View filing
O'hara John Charles Chief Financial Officer Jun 5, 2026 Same-day filing Sale Jun 5, 2026 $501.93 Filed shares x price SEC Form 4 View filing
Enguent Jean-pierre Vice President, R&dss
Sale
Calculated transaction value
$48.33K 35,000 shares @ $1.38
Traded
Nov 3, 2026
Filed
Nov 3, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$200 20,000 shares @ $0.01
Traded
Nov 2, 2026
Filed
Nov 3, 2026
Enguent Jean-pierre Vice President, R&dss
Award
Calculated transaction value
$0 50,000 shares @ $0
Traded
Nov 2, 2026
Filed
Nov 3, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$150 15,000 shares @ $0.01
Traded
Nov 2, 2026
Filed
Nov 3, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$0 15,000 shares @ $0
Traded
Nov 2, 2026
Filed
Nov 3, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$0 20,000 shares @ $0
Traded
Nov 2, 2026
Filed
Nov 3, 2026
Enguent Jean-pierre Vice President, R&dss
Sale
Calculated transaction value
$85.94K 35,000 shares @ $2.46
Traded
Oct 6, 2026
Filed
Oct 7, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$350 35,000 shares @ $0.01
Traded
Oct 5, 2026
Filed
Oct 7, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$0 35,000 shares @ $0
Traded
Oct 5, 2026
Filed
Oct 7, 2026
Enguent Jean-pierre Vice President, R&dss
Award
Calculated transaction value
$0 50,000 shares @ $0
Traded
Oct 5, 2026
Filed
Oct 7, 2026
Ward Peter Director
Award
Calculated transaction value
$0 4,686 shares @ $0
Traded
Oct 5, 2026
Filed
Oct 6, 2026
Ward Peter Director
Award
Calculated transaction value
$0 3,582 shares @ $0
Traded
Oct 5, 2026
Filed
Oct 6, 2026
Fergusson David Alexander Director
Award
Calculated transaction value
$0 14,063 shares @ $0
Traded
Sep 25, 2026
Filed
Oct 6, 2026
Fergusson David Alexander Director
Award
Calculated transaction value
$0 3,424 shares @ $0
Traded
Sep 25, 2026
Filed
Oct 6, 2026
Pellaton Eric Adrien Director
Award
Calculated transaction value
$0 10,747 shares @ $0
Traded
Sep 25, 2026
Filed
Oct 6, 2026
Pellaton Eric Adrien Director
Award
Calculated transaction value
$0 14,063 shares @ $0
Traded
Sep 25, 2026
Filed
Oct 6, 2026
Enguent Jean-pierre Vice President, R&dss
Sale
Calculated transaction value
$36.03K 15,000 shares @ $2.4
Traded
Sep 3, 2026
Filed
Sep 3, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$0 15,000 shares @ $0
Traded
Sep 1, 2026
Filed
Sep 3, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$150 15,000 shares @ $0.01
Traded
Sep 1, 2026
Filed
Sep 3, 2026
Enguent Jean Pierre Vice President, R&Dss
Sale
Calculated transaction value
$36.86K 15,000 shares @ $2.46
Traded
Aug 5, 2026
Filed
Aug 5, 2026
Enguent Jean Pierre Vice President, R&Dss
Exercise
Calculated transaction value
$150 15,000 shares @ $0.01
Traded
Aug 3, 2026
Filed
Aug 5, 2026
Enguent Jean Pierre Vice President, R&Dss
Exercise
Calculated transaction value
$0 15,000 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 5, 2026
Enguent Jean-pierre Vice President, R&dss
Sale
Calculated transaction value
$42.27K 15,000 shares @ $2.82
Traded
Jul 8, 2026
Filed
Jul 8, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$0 15,000 shares @ $0
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Enguent Jean-pierre Vice President, R&dss
Exercise
Calculated transaction value
$150 15,000 shares @ $0.01
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Ward Peter Director
Disposition
Calculated transaction value
$296.35K 96,530 shares @ $3.07
Traded
Jun 16, 2026
Filed
Jun 18, 2026
Ward Peter Director
Exercise
Calculated transaction value
$3.67K 366,746 shares @ $0.01
Traded
Jun 16, 2026
Filed
Jun 18, 2026
Ward Peter Director
Exercise
Calculated transaction value
$0 353,097 shares @ $0
Traded
Jun 16, 2026
Filed
Jun 18, 2026
Ward Peter Director
Exercise
Calculated transaction value
$0 13,649 shares @ $0
Traded
Jun 16, 2026
Filed
Jun 18, 2026
O'hara John Charles Chief Financial Officer
Sale
Calculated transaction value
$501.93 143 shares @ $3.51
Traded
Jun 5, 2026
Filed
Jun 5, 2026